Allink Biotherapeutics Funding: $89M Raised, Series A (2025)

Allink Biotherapeutics is based in Shanghai, China. It has raised $89M in total funding. Latest round: Series A.

Allink Biotherapeutics funding overview

Allink Biotherapeutics is based in Shanghai, China. Allink Biotherapeutics has raised $89M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for Allink Biotherapeutics runs through 2025; nothing later has been disclosed. Investors on record include Lanchi Ventures, Yuanbio Venture Capital, Legend Capital, C&D Emerging Industry Equity Investment, Gaorong Ventures, Med-Fine Capital and 4 others. 10 distinct backers are named across the disclosed rounds.

Allink Biotherapeutics at a glance

Total raised
$89M
Latest round
Series A
Latest round date
December 2025
Headquarters
Shanghai, China
Notable investors
Lanchi Ventures, Yuanbio Venture Capital, Legend Capital, C&D Emerging Industry Equity Investment, Gaorong Ventures, Med-Fine Capital, Meituan Long-Z Investment, 5Y Capital

Frequently asked about Allink Biotherapeutics funding

How much has Allink Biotherapeutics raised?
Allink Biotherapeutics has raised $89M in total disclosed funding across the rounds on record.
Who has invested in Allink Biotherapeutics?
Lanchi Ventures, Yuanbio Venture Capital, Legend Capital, C&D Emerging Industry Equity Investment, Gaorong Ventures, Med-Fine Capital are named among the investors backing Allink Biotherapeutics.
What was the latest Allink Biotherapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2025.
Where is Allink Biotherapeutics based?
Allink Biotherapeutics is based in Shanghai, China.
When did Allink Biotherapeutics last raise?
The last disclosed Allink Biotherapeutics round closed in December 2025 at Series A.

Round data for Allink Biotherapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.

Companies related to Allink Biotherapeutics (20)

Browse related funding lists (8)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades